Interventional Oncology <h1 class="header1">Interventional Oncology News</h1> en BIBA Medical Ltd Fri, 29 Aug 2014 17:19:02 GMT 3360 Affino 5 RSS Generator The microenvironment of solid tumours matters <div style="display:block;"> <div id="ImageThumb1" style="float:left;"><a href=""><img src="" border="0" hspace="5" vspace="5" /></a></div> <div id="ItemTeaser1" style="float:left;"> Despite the rapid growth of imaging and treatment options in interventional oncology, one area that has been poorly understood and overlooked by the interventional community is the role of the tumour microenvironment and its impact on the delivery of therapeutic agents, writes Aravind Arepally. </div> </div> Fri, 08 Aug 2014 16:28:00 +0000 Vascular Solutions launches Gel-Bead bioresorbable embolization spheres <div style="display:block;"> <div id="ItemTeaser2" style="float:left;"> Vascular Solutions has announced the US market launch of its Gel-Bead embolization spheres for the treatment of hypervascular tumours. </div> </div> Fri, 01 Aug 2014 11:50:00 +0000 Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment <div style="display:block;"> <div id="ImageThumb3" style="float:left;"><a href=""><img src="" border="0" hspace="5" vspace="5" /></a></div> <div id="ItemTeaser3" style="float:left;"> The study followed patients at five leading academic centres and found a significant decrease (p <0.01) in pain scores after targeted radiofrequency ablation (t-RFA) with the Star (DFINE) tumour ablation system. </div> </div> Wed, 23 Jul 2014 14:04:00 +0000 Liver tumour ablation more predictable with Emprint <div style="display:block;"> <div id="ImageThumb4" style="float:left;"><a href=""><img src="" border="0" hspace="5" vspace="5" /></a></div> <div id="ItemTeaser4" style="float:left;"> Covidien has unveiled an advanced ablation system that offers physicians predictable results regardless of the target location or tissue type. </div> </div> Thu, 17 Jul 2014 15:36:00 +0000 Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy <div style="display:block;"> <div id="ImageThumb5" style="float:left;"><a href=""><img src="" border="0" hspace="5" vspace="5" /></a></div> <div id="ItemTeaser5" style="float:left;"> Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or small intestine can result in serious complications, especially gastrointestinal ulcerations, particularly with Y-90 microspheres. Now, temporary antireflux devices are available that appear to provide both adequate retrograde and antegrade protection against nontarget delivery of cytotoxic agents, </div> </div> Tue, 08 Jul 2014 14:49:00 +0000